title: Lipoprotein apheresis.
abstract: OBJECTIVE
  Lipoprotein apheresis is being performed with increasing frequency, but better data collection and recording of clinical outcomes are needed. Setting up registries would facilitate this process.
  
  
  RESULTS
  This review appraises recent articles that discuss the need for national registries and requirements for setting them up, the efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia and patients with coronary disease secondary to raised levels of lipoprotein (a), and its role in the management of acute pancreatitis secondary to severe hypertriglyceridaemia.
  
  
  CONCLUSIONS
  Lipoprotein apheresis seems to be going through a growth spurt, presumably reflecting better implementation of treatment guidelines or a broadening of indications for its use.
authors.affiliation: Metabolic Medicine, Imperial College, Hammersmith Hospital, London, UK. g.thompson@imperial.ac.uk
authors.forename: Gilbert R
authors.initials: GR
authors.lastname: Thompson
mesh_terms: D001781:Blood Component Removal; D003327:Coronary Disease / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000517:prevention & control / Q000628:therapy; D015228:Hypertriglyceridemia / Q000097:blood / Q000517:prevention & control / Q000628:therapy; D017270:Lipoprotein(a) / Q000097:blood / Q000302:isolation & purification; D019283:Pancreatitis, Acute Necrotizing / Q000517:prevention & control / Q000628:therapy; D012042:Registries; D012307:Risk Factors; D016896:Treatment Outcome; D006113:United Kingdom
chemical_list: D017270:Lipoprotein(a)